Merck & Co., Inc.'s 4.09% dividend yield and robust pipeline signal strong growth potential. Click here to read an analysis ...

A federal court denied Johnson & Johnson's motion to implement a 340B drug rebate model, siding with HHS and hospitals who ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

Moderna disclosed that a study of 56,000 volunteers older than 50 found its new mRNA flu vaccine was more effective than an ...

These three of the best Dividend Aristocrats to buy now with $1,000 as they all trade for less than $25 per share.

Johnson & Johnson (NYSE:JNJ) is one of the 12 stocks that will make you rich in 10 years. On June 23, J&J announced new data ...

Johnson & Johnson (NYSE: JNJ) is an iconic U.S. healthcare giant. There are a lot of positives with J&J, as it is more ...

Mounjaro is one of the bestselling weight loss drugs. See what your options are if you want to invest in Mounjaro stock.

Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.

That totals $26.4 million to Democrats and $16.1 million to Republicans in 2023-2024 from pharmaceutical and health product companies, with Democrats receiving noticeably more. (Although Big Pharma ...

Webcast and conference call to be held on Monday, June 30th at 4:30 pm ET, dial in information below NEWARK, CA / ACCESS Newswire / June 26, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the ...